Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT05129904

Precise Profiling of Liver Disease Patients With DPMAS Therapy, Treating Optimal Patients and Achieving Hard Endpoint (PADSTONE Study)

Sponsor: Nanfang Hospital, Southern Medical University

View on ClinicalTrials.gov

Summary

Acute-on-chronic liver failure (ACLF) is a life-threatening syndrome occurring in patients with chronic liver disease. In China, hepatitis B virus (HBV) is the main cause of cirrhosis. HBV related ACLF is characterized by multiple organs failure (liver, coagulation and kidney, etc.) and confers with high risk of short-term mortality. For the treatment of ACLF patients, recent studies have explored the therapeutic efficacy of extracorporeal liver support therapies, such as albumin dialysis, plasma exchange. However, the clinical efficacy remains to be fully elucidated. Liver transplantation is the most efficient way to improve the survival of ACLF patients, especially for those suffering from three or more organ failures. Recently, a novel extracorporeal system which is called double plasma molecular adsorption system (DPMAS) has been applied for the treatment of ACLF patients. DPMAS is an extracorporeal therapeutic procedure that combines two hemoperfusion devices. During treatment, toxic plasma is isolated and purified via perfusion through two adsorbers, after which the purified plasma is reinfused back into the patient's circulation. This technique requires no massive plasma supply and avoids the risks of plasma-related allergic reactions and pathogen transmission. DPMAS can rapidly alleviate jaundice and lower serum bilirubin levels, thereby mitigating the hepatotoxic effects induced by excessive bilirubin and bile acids. Despite the widespread clinical application of DPMAS in patients with liver failure, high-quality evidence supporting its definite clinical efficacy remains insufficient. Accordingly, this prospective, multicenter cluster-controlled study is designed to evaluate the clinical benefits of DPMAS via validated hard clinical endpoints, including short-term mortality and disease progression, and screen out suitable candidate patients. Furthermore, biological specimens including plasma, urine and feces will be collected to characterize the molecular profiles of ACLF patients receiving DPMAS treatment through multi-omics analyses.

Official title: Precise Profiling of Liver Disease Patients With DPMAS Therapy, Treating Optimal Patients and Achieving Hard Endpoint: a Multicenter, Cluster-controlled Study (PADSTONE Study)

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

1300

Start Date

2021-09-15

Completion Date

2026-09-30

Last Updated

2026-05-26

Healthy Volunteers

No

Interventions

OTHER

Double plasma molecular absorption system

As a type of ECLS, double plasma molecular adsorption system (DPMAS) integrates plasma filtration with two specific adsorption membranes, which can efficiently remove bilirubin and the middle-molecular toxins, respectively. In the DPMAS clusters, patients receive at least one DPMAS treatment session during the study period, as treatment details regarding the number of DPMAS sessions and session intervals are made upon institutional protocols. DPMAS treatment can be applied either alone or in combination with PE, and both modalities are permitted in this study. PE is allowed in both groups as standard supportive care.

Locations (56)

The Second Affiliated Hospital of Chongqing Medical University

Chongqing, Chongqing Municipality, China

Nanfang Hospital

Guangzhou, Guangdong, China

The Third Hospital of Hebei Medical University

Hebei, Hebei, China

Hunan Provincial People's Hospital

Changsha, Hunan, China

Xiangya Hospital of Central South University

Changsha, Hunan, China

Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School

Nanjing, Jiangsu, China

The Affiliated Hospital of Xuzhou Medical University

Xuzhou, Jiangsu, China

The First Affiliated Hospital of Nanchang University

Nanchang, Jiangxi, China

The Second Affiliated Hospital Of Nanchang University

Nanchang, Jiangxi, China

The First Hospital of Jilin University

Changchun, Jilin, China

Qilu Hospital of Shandong University

Jinan, Shandong, China

Shandong Provincial Clinical Center for Public Health

Jinan, Shandong, China

The First Affiliated Hospital of Shandong First Medical University

Jinan, Shandong, China

The Second Hospital of Shandong University

Jinan, Shandong, China

Sichuan Provincial People's Hospital

Chengdu, Sichuan, China

West China Hospital of Sichuan University

Chengdu, Sichuan, China

The First Hospital of Yunnan Province

Kunming, Yunnan, China

Beijing Ditan Hospital, Capital Medical University

Beijing, China

Beijing Youan Hospital, Capital Medical University

Beijing, China

Luhe Hospital, Capital Medical University

Beijing, China

Peking University People's Hospital

Beijing, China

The Second Xiangya Hospital, Central South University

Changsha, China

Chengdu Public Health Clinical Center

Chengdu, China

Southwest Hospital, Third Military Medical University

Chongqing, China

The First People's Hospital of Foshan

Foshan, China

First Affiliated Hospital of Fujian Medical University

Fujian, China

Mengchao Hepatobiliary Hospital of Fujian Medical University

Fujian, China

The First Affiliated Hospital of Guangxi Medical University

Guangxi, China

The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine

Guangxi, China

The People's Hospital of Guangxi Zhuang Autonomous Region

Guangxi, China

The Second Affiliated Hospital of Guangxi Medical University

Guangxi, China

Guizhou Provincial People's Hospital

Guizhou, China

The Affiliated Hospital of Guizhou Medical University

Guizhou, China

The Affiliated Hospital of Zunyi Medical University

Guizhou, China

Hainan Provincial People's Hospital

Hainan, China

The Second Hospital of Hebei Medical University

Hebei, China

First Affiliated Hospital of Anhui Medical University

Hefei, China

Henan Provincial People's Hospital

Henan, China

Taihe Hospital, Hubei University of Medicine

Hubei, China

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Hubei, China

The Second Affiliated Hospital of Kunming Medical University

Kunming, China

The First Hospital of Lanzhou University

Lanzhou, China

Zhengzhou University Affiliated Luoyang Centre Hospital

Luoyang, China

Infectious Diseases Hospital Affiliated to Nanchang University

Nanchang, China

General Hospital of Ningxia Medical University

Qinghai, China

Huashan Hospital, Fudan University

Shanghai, China

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

Shanghai, China

Shanghai Jiao Tong University Affiliated Sixth People's Hospital

Shanghai, China

Shanghai Public Health Clinical Centre, Fudan University

Shanghai, China

Shanghai Public Health Clinical Centre

Shanghai, China

The First Affiliated Hospital of Shanxi Medical University

Shanxi, China

Tianjin Third Central Hospital

Tianjin, China

The First Affiliated Hospital of Xi'an Jiaotong University

Xi'an, China

The First Affiliated Hospital of Xinjiang Medical University

Xinjiang, China

The First Affiliated Hospital, Zhejiang University School of Medicine

Zhejiang, China

The First Affiliated Hospital of Zhengzhou University

Zhengzhou, China